Beilu Pharmaceutical Intends to Establish a Wholly-owned Subsidiary in Hong Kong

In order to further expand overseas markets and meet the needs of the company's strategic development, Beilu Pharmaceutical intends to establish a wholly-owned subsidiary in Hong Kong.

Actively expanding overseas markets and promoting international layout are the priorities of the company's work. With this goal, the company actively expands the overseas registration, declaration and sales of various products.

The establishment of a wholly-owned subsidiary in Hong Kong will help the company rely on Hong Kong's geographical advantages to accelerate the development of overseas business, further improve the company's market competitiveness and brand awareness, and have a positive impact on the company's long-term development and strategic layout.